Patent details

EP3529359 Title: TUMOR INFILTRATING LYMPHOCYTES FOR USE IN THERAPY

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP3529359
WO Application Number:
US2017057228
Type:
European Patent Granted for NL
Status:
Patent in Force
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP17861792.4
WO Publication Number:
WO2018075664
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
United States of America (US)
Publications:

Dates

Filing date:
18/10/2017
Grant date:
13/12/2023
EP Publication Date:
28/08/2019
WO Publication Date:
26/04/2018
Claims Translations Received Date:
Claims Translation B1 Received Date:
12/03/2024
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
13/12/2023
EP B1 Publication Date:
13/12/2023
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
17/10/2037
Lapsed By Expiration Date:
Patent Validated Date:
15/03/2024
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
13/12/2023
 
 

 

Name:
Regents of the University of Minnesota
Address:
600 McNamara Alumni Center 200 Oak Street S.E., Minneapolis, MN 55455-2020, United States of America (US)

From:
13/12/2023
 
 

 

Name:
Intima Bioscience, Inc.
Address:
3 Columbus Circle, New York, New York 10019, United States of America (US)

From:
13/12/2023
 
 

 

Name:
The United States of America, as represented by the Secretary, Department of Health and Human Services
Address:
Office of Technology Transfer, National Institutes of Health, 6011 Executive Boulevard, Suite 325, MSC 7660,, Bethesda, MD 20892-7660, United States of America (US)

Agent

Name:
dr. R.C. van Duijvenbode c.s.
From:
14/03/2024
Address:
NLO Postbus 29720, 2502 LS, Den Haag, Netherlands (NL)
To:

Inventor

1

Name:
MORIARITY, Branden
Address:
Shoreview MN 55126-8516, United States of America (US)

2

Name:
WEBBER, Beau
Address:
Coon Rapids Minnesota 55448, United States of America (US)

3

Name:
CHOUDHRY, Modassir
Address:
New York New York 10019, United States of America (US)

4

Name:
ROSENBERG, Steven A.
Address:
Potomac Maryland 20854, United States of America (US)

5

Name:
PALMER, Douglas C.
Address:
N. Bethesda MD 20852, United States of America (US)

6

Name:
RESTIFO, Nicholas P.
Address:
Chevy Chase Maryland 20815, United States of America (US)

Priority

1

Priority Patent Number:
201762452244 P
Priority Date:
30/01/2017
Priority Country:
United States of America (US)

2

Priority Patent Number:
201662409651 P
Priority Date:
18/10/2016
Priority Country:
United States of America (US)

Classification

IPC or IDT classification:
A61K 35/17; A61P 35/02; A61P 35/00; A61P 31/12; C07K 14/715; C07K 14/705; C07K 14/47; C12N 9/22; C12N 15/113; A61P 31/00;

Publication

Bulletin

1

Bulletin Heading:
EP3
Journal edition number:
12/24
Publication date:
20/03/2024
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

2

Bulletin Heading:
EP2
Journal edition number:
50/23
Publication date:
13/12/2023
Description:
European patents granted for the Netherlands

European Patent Bulletin

1

Issue number:
202401
Publication date:
03/01/2024
Description:
Application number/publication number of the divisional application (Art. 76) changed

2

Issue number:
202350
Publication date:
13/12/2023
Description:
Grant (B1)

Annual Fee

Annual Fee(s) Due Date:
31/10/2025
Annual Fee Number:
9
Annual Fee Amount:
340 Euro
Last Annual Payment Date:
03/05/2024
Last Annual Fee Paid Number:
8
Last Annual Fee Paid Amount:
280 Euro
Payer:
NLO
Filing date Document type Document Description Number of pages File Type
14/03/2024 Outgoing Correspondence Letter no formal defects 1 PDF /5/6/7/1/5/0800951765/docs/ep17861792.4_0_596689l271.pdf
12/03/2024 Claims First filed claims 3 PDF /5/6/7/1/5/0800951765/docs/ep17861792.4_1_claims20240312084514918.pdf